PolarityTE confirmed that on November 1, 2022, it received an unsolicited, non-binding offer (followed by an amended offer on November 8, 2022) from Michael Brauser to acquire all of the outstanding common stock of the Company not owned by him for $1.25 per share in cash.

Posted in BioUtah News | Tagged polarityTE | Leave a comment

Clene Announces $10.8 Million Registered Direct Offering and $5 Million Debt Facility from the State of Maryland

By Press Release | Published November 2, 2022

Clene announced that it has entered into a securities purchase agreement with certain existing stockholders.

Posted in BioUtah News | Tagged clene nanomedicine | Leave a comment

Clene Reports Topline Results Demonstrating Survival Signal for CNM-Au8® in Healey ALS Platform Trial

By Press Release | Published November 2, 2022

The primary endpoint of adjusted ALSFRS-R and secondary endpoints of CAFS and SVC were not met at 24 weeks Prespecified exploratory analyses of the secondary survival endpoint for the 30 mg dose demonstrated a >90% reduction in risk of death or risk of death/permanently assisted ventilation at 24 weeks Survival signal consistent with prior results […]

Posted in BioUtah News | Tagged clene nanomedicine | Leave a comment

Myriad Genetics Expands Consumer Access to Genetic Testing with Acquisition of Gateway Genomics and Its Market-Leading SneakPeek® Early Gender DNA Test

By Press Release | Published November 2, 2022

$67.5 million tuck-in acquisition strengthens Myriad’s Women’s Health portfolio of prenatal products.

Posted in BioUtah News | Tagged myriad genetics | Leave a comment

Myriad Genetics Reports Third Quarter Financial Results

By Press Release | Published November 2, 2022

Myriad Genetics announced financial results for its third quarter ended September 30, 2022 and provided an update on business performance.

Posted in BioUtah News | Tagged myriad genetics | Leave a comment

Renalytix Reports Full Year Fiscal 2022 Results

By Press Release | Published November 1, 2022

Renalytix announced its full year results for the twelve months ended 30 June 2022.

Posted in BioUtah News | Tagged renalytix | Leave a comment

Merit Medical Reports Results for Quarter Ended September 30, 2022

By Press Release | Published November 1, 2022

Merit Medical Systems announced revenue of $287.2 million for the quarter ended September 30, 2022.

Posted in BioUtah News | Tagged merit medical | Leave a comment

UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2022

By Press Release | Published October 27, 2022

UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2022

Posted in BioUtah News | Tagged utah medical products | Leave a comment

Author Archives: Press Release

A Special Thanks To Our Elite Members